Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gibble

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Diabetes, Obesity & Metabolism|March 14, 2025
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® databaseTheresa Hunter Gibble, Chanadda Chinthammit, Jennifer M Ward, et al.
Crohn'S & Colitis 360|February 13, 2023
Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease RemissionMarla C Dubinsky, David B Clemow, Theresa Hunter Gibble, et al.
Obesity (Silver Spring, Md.)|November 4, 2025
People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide TreatmentXuan Li, Dachuang Cao, Helene Sapin, et al.
Transfusion|September 1, 1983
Red cell sensitization due to anti-D in anti-lymphocyte globulinR S Shirey, B Smith, L Sensenbrenner, et al.
Diabetes, Obesity & Metabolism|February 25, 2025
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweightMichelle Look, Julia P Dunn, Robert F Kushner, et al.
Current Medical Research and Opinion|August 7, 2023
Clinical profiles and outcomes in patients with ulcerative colitis receiving standard and higher-than-standard doses of vedolizumab: findings from a real-world study in EuropeJavier P Gisbert, Petra Streit, Isabel Redondo, et al.
Journal of Wildlife Diseases|March 17, 2018
Investigation of a Largescale Common Murre ( Uria aalge) Mortality Event in California, USA, in 2015Corinne Gibble, Rebecca Duerr, Barbara Bodenstein, et al.
The Journal of Rheumatology|February 1, 2023
Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab TrialsUta Kiltz, Désirée van der Heijde, Annelies Boonen, et al.
Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Inflammatory Bowel Diseases|March 21, 2024
Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn's DiseaseVipul Jairath, Theresa Hunter Gibble, Alison Potts Bleakman, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Diabetes, Obesity & Metabolism|March 14, 2025
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® databaseTheresa Hunter Gibble, Chanadda Chinthammit, Jennifer M Ward, et al.
Crohn'S & Colitis 360|February 13, 2023
Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease RemissionMarla C Dubinsky, David B Clemow, Theresa Hunter Gibble, et al.
Obesity (Silver Spring, Md.)|November 4, 2025
People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide TreatmentXuan Li, Dachuang Cao, Helene Sapin, et al.
Transfusion|September 1, 1983
Red cell sensitization due to anti-D in anti-lymphocyte globulinR S Shirey, B Smith, L Sensenbrenner, et al.
Diabetes, Obesity & Metabolism|February 25, 2025
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweightMichelle Look, Julia P Dunn, Robert F Kushner, et al.
Current Medical Research and Opinion|August 7, 2023
Clinical profiles and outcomes in patients with ulcerative colitis receiving standard and higher-than-standard doses of vedolizumab: findings from a real-world study in EuropeJavier P Gisbert, Petra Streit, Isabel Redondo, et al.
Journal of Wildlife Diseases|March 17, 2018
Investigation of a Largescale Common Murre ( Uria aalge) Mortality Event in California, USA, in 2015Corinne Gibble, Rebecca Duerr, Barbara Bodenstein, et al.
The Journal of Rheumatology|February 1, 2023
Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab TrialsUta Kiltz, Désirée van der Heijde, Annelies Boonen, et al.
Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Inflammatory Bowel Diseases|March 21, 2024
Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn's DiseaseVipul Jairath, Theresa Hunter Gibble, Alison Potts Bleakman, et al.
Pageof 13